# US launches trial testing semaglutide for alcohol addiction 2026-08-07T14:09:37+00:00 | Health & Science | Indian Opinion Desk Corroboration: 1 independent outlet The US Department of Veterans Affairs has launched a nationwide clinical trial testing whether semaglutide, the active ingredient in Ozempic and Wegovy, can help people with alcohol use disorder drink less. The CRAVE trial will enrol over 600 veterans at 18 medical centres across the country. Participants will receive weekly injections of semaglutide or a placebo for 24 weeks. Researchers will measure changes in alcohol consumption, cravings, and quality of life. No new medication for alcohol addiction has been approved by the FDA in nearly 20 years, and fewer than 2 per cent of US adults with the disorder receive medication-based treatment annually. Early studies suggest GLP-1 drugs may reduce cravings by affecting the brain's reward system. ## Coverage - timesnownews.com Tags: addiction treatment, alcohol use disorder, clinical trial, GLP-1, semaglutide, veterans Canonical: https://indianopinion.org/us-launches-trial-testing-semaglutide-for-alcohol-addiction/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/us-launches-trial-testing-semaglutide-for-alcohol-addiction/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes.